| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 1975,
Authors: 5409,
Journals: 512,
Outer References: 13295,
Words: 3300
Collection span: 1980 - 2004
View: Overview. Sorted by journal name.
Page 7: 1 2 3 4 5 6 7
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1801 | 0 | 2 | 213 1987 PRENATAL DIAGNOSIS 7(4):295-298 GOLLOP TR; EIGIER A PRENATAL-DIAGNOSIS OF THALIDOMIDE SYNDROME | 5 | 6 |
| 1802 | 0 | 2 | 94 1983 PRESSE MEDICALE 12(15):963-963 BARRIERE H SARCOIDOSIS OF THE SKIN - TREATMENT WITH THALIDOMIDE | 12 | 16 |
| 1803 | 2 | 4 | 95 1983 PRESSE MEDICALE 12(47):3007-3007 PRIGENT F; OUAZZANI W SARCOIDOSIS OF THE SKIN - TREATMENT WITH THALIDOMIDE | 4 | 4 |
| 1804 | 0 | 2 | 291 1990 PRESSE MEDICALE 19(15):722-722 LIVROZET JM; FRANC C; GRANIER JL; BRETON P; TOURAINE JL THALIDOMIDE TREATMENT OF CHOICE OF APHTHAE IN HIV-INFECTION - REPLY | 0 | 0 |
| 1805 | 1 | 4 | 292 1990 PRESSE MEDICALE 19(15):722-722 SAMSON J; KUFFER R; RADEFF B THALIDOMIDE TREATMENT OF CHOICE OF APHTHAE IN HIV-INFECTION | 2 | 2 |
| 1806 | 1 | 3 | 374 1993 PRESSE MEDICALE 22(1):37-37 PEDAILLES S; TROUSSARD X; LAUNAY V; BAZIN A; SENTIAS C; SURBLED M SCLERODERMATOUS SKIN REACTION IN GRAFT-VERSUS-HOST DISEASE TREATED WITH THALIDOMIDE | 2 | 2 |
| 1807 | 2 | 3 | 375 1993 PRESSE MEDICALE 22(26):1233-1233 BODOKH I; LACOUR JP; RAINERO C; CASTANET J; MICHIELS JF; ORTONNE JP EFFECTIVENESS OF THALIDOMIDE AGAINST ESOPHAGEAL ULCERATION IN HIV-INFECTION | 3 | 3 |
| 1808 | 2 | 3 | 484 1995 PRESSE MEDICALE 24(1):40-40 COUDERC LJ; MATHEZ D; LEIBOWITCH J; AUTRAN B; CAUBARRERE I PROLONGED THALIDOMIDE TREATMENT IN AN HIV-INFECTED PATIENT | 0 | 1 |
| 1809 | 2 | 3 | 1262 2001 PRESSE MEDICALE 30(20):1008-1009 Pouaha J; Martin S; Trechot P; Truchetet F; Barbaud A; Schmutz JL Thalidomide and thrombosis: three cases | 5 | 5 |
| 1810 | 7 | 11 | 1815 2003 PRESSE MEDICALE 32(40):1894-1898 Brocvielle H; Muret P; Plenat E; Kantelip JP; Humbert P Management of a patient receiving thalidomide | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1811 | 1 | 24 | 376 1993 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90(13):5974-5978 MAKONKAWKEYOON S; LIMSONPOBRE RNR; MOREIRA AL; SCHAUF V; KAPLAN G THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 | 105 | 184 |
| 1812 | 8 | 29 | 424 1994 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91(9):4082-4085 DAMATO RJ; LOUGHNAN MS; FLYNN E; FOLKMAN J THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS | 333 | 732 |
| 1813 | 10 | 32 | 557 1996 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 93(15):7552-7556 Turk BE; Jiang H; Liu JO Binding of thalidomide to alpha(1)-acid glyeoprotein may be involved in its inhibition of tumor necrosis factor alpha production | 40 | 50 |
| 1814 | 0 | 24 | 26 1981 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 78(4):2545-2548 GORDON GB; SPIELBERG SP; BLAKE DA; BALASUBRAMANIAN V THALIDOMIDE TERATOGENESIS - EVIDENCE FOR A TOXIC ARENE OXIDE METABOLITE | 48 | 89 |
| 1815 | 0 | 17 | 169 1985 PSYCHOPHARMACOLOGY 85(1):47-50 KAITIN KI EFFECTS OF THALIDOMIDE AND PENTOBARBITAL ON NEURONAL-ACTIVITY IN THE PREOPTIC AREA DURING SLEEP AND WAKEFULNESS IN THE CAT | 3 | 6 |
| 1816 | 16 | 59 | 1047 2000 QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS 93(5):305-311 Davey PP; Ashrafian H New therapies for heart failure: is thalidomide the answer? | 6 | 9 |
| 1817 | 20 | 48 | 1263 2001 QUIMICA NOVA 24(5):683-688 Lima LM; Fraga CAM; Barreiro EJ The rebirth of a drug: Thalidomide | 0 | 1 |
| 1818 | 5 | 25 | 1548 2002 RADIOLOGE 42(3):222-230 Scherer A; Strupp C; Wittsack HJ; Engelbrecht V; Willers R; Germing U; Gattermann N; Haas R; Modder U Dynamic contrast-enhanced MRI for the evaluation of bone marrow microcirculation in hematologic malignancies before and during thalidomide therapy | 0 | 0 |
| 1819 | 0 | 0 | 1264 2001 RADIOLOGY 221:387-387 Faria SC; Charnsangavej C; Sawaf Y; Hess KR; Tamm EP; Lee T CT quantification of antiangiogenic effects of thalidomide | 0 | 0 |
| 1820 | 0 | 32 | 27 1981 REHABILITATION 20(3):128-132 WEINWURMKRAUSE EM PARTNERSHIP AND SEXUALITY OF THALIDOMIDE-AFFECTED YOUNG-PEOPLE | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1821 | 0 | 18 | 28 1981 REHABILITATION 20(4):159-164 WEINWURMKRAUSE EM THE SITUATION OF THALIDOMIDE-AFFECTED YOUNG-PEOPLE IN CHOOSING AN OCCUPATION | 0 | 2 |
| 1822 | 0 | 0 | 558 1996 REPRODUCTIVE TOXICOLOGY 10(1):1-2 Robert E Thalidomide and isotretinoin - Why treat them differently? | 2 | 6 |
| 1823 | 8 | 40 | 862 1999 REPRODUCTIVE TOXICOLOGY 13(6):547-554 Hansen JM; Carney EW; Harris C Differential alteration by thalidomide of the glutathione content of rat vs. rabbit conceptuses in vitro | 6 | 11 |
| 1824 | 5 | 32 | 648 1997 RESPIRATORY MEDICINE 91(1):31-39 Tavares JL; Wangoo A; Dilworth P; Marshall B; Kotecha S; Shaw RJ Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages | 24 | 39 |
| 1825 | 0 | 0 | 425 1994 REVISTA BRASILEIRA DE GENETICA 17(4):449-464 SALDANHA PH THE THALIDOMIDE-TRAGEDY AND THE BIRTH OF EXPERIMENTAL TERATOLOGY | 0 | 0 |
| 1826 | 2 | 7 | 559 1996 REVISTA CLINICA ESPANOLA 196(4):270-271 Tercedor J; delaTorre ML; Rodenas JM Disseminated xanthoma with insipid diabetes: Therapeutic failure of thalidomide | 0 | 0 |
| 1827 | 2 | 15 | 194 1986 REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO 28(1):12-14 ARRUDA WO; HACBARTH E; DOI E; SANTAMARIA JR; BARBOSA J; KAJDACSYBALLA AA EFFECT OF THALIDOMIDE ON SERUM LEVELS OF IMMUNOGLOBULINS IGM AND IGA, RHEUMATOID-FACTOR AND ISOHEMAGLUTININS ANTI-A AND ANTI-B IN PATIENTS WITH LEPROMATOUS LEPROSY - A DOUBLE-BLIND-STUDY | 1 | 2 |
| 1828 | 8 | 11 | 739 1998 REVUE DE MEDECINE INTERNE 19(3):196-198 Lair G; Marie I; Cailleux N; Blot E; Boullie MC; Courville P; Lauret P; Levesque H; Courtois H Langerhans cell histiocytosis in adult patients: cutaneous and mucous localizations improving with thalidomide | 9 | 13 |
| 1829 | 3 | 5 | 740 1998 REVUE DE MEDECINE INTERNE 19(3):208-209 Grasland A; Pouchot J; Chaumaiziere D; Aitken G; Vinceneux P Effectiveness of thalidomide in cutaneous sarcoidosis | 3 | 4 |
| 1830 | 12 | 17 | 863 1999 REVUE DE MEDECINE INTERNE 20(7):567-570 de Wazieres B; Gil H; Magy N; Berthier S; Vuitton DA; Dupond JL Treatment of recurrent oro-genital ulceration with low dose of thalidomide. Pilot study in 17 patients | 3 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1831 | 13 | 18 | 1265 2001 REVUE DE MEDECINE INTERNE 22(1):5-7 Grosbois B; Duguet C Thalidomide: the revival | 2 | 4 |
| 1832 | 11 | 15 | 1549 2002 REVUE DE MEDECINE INTERNE 23(7):651-656 Claudon A; Dietemann JL; De Compte AH; Hassler P Interest of thalidomide in cutaneo-mucous and hypothalamo-hypophyseal in Langerhans cell histiocytosis. | 1 | 1 |
| 1833 | 8 | 11 | 1550 2002 REVUE DE MEDECINE INTERNE 23(8):724-727 Gachon J; Grob JJ; Richard MA Thalidomide treatment leading thrombotic events: two cases | 3 | 4 |
| 1834 | 1 | 6 | 125 1984 REVUE DU RHUMATISME 51(10):585-585 TREVES R; ARNAUD M; JACOB P; LUBEAU M; TABARAUD F; BURKI F; DESPROGESGOTTERON R DRAMATIC IMPROVEMENT IN THE ARTHRITIS OF BEHCETS-DISEASE FOLLOWING THE ADMINISTRATION OF THALIDOMIDE - A CASE-REPORT | 3 | 5 |
| 1835 | 6 | 30 | 170 1985 REVUE NEUROLOGIQUE 141(11):719-728 CHAPON F; LECHEVALIER B; DASILVA DC; RIVRAIN Y; DUPUY B; DESCHAMPS P THALIDOMIDE INDUCED NEUROPATHY | 5 | 8 |
| 1836 | 10 | 48 | 1816 2003 RHEUMATIC DISEASE CLINICS OF NORTH AMERICA 29(3):481-+ Davis JC; Huang F; Maksymowych W New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate | 0 | 0 |
| 1837 | 11 | 41 | 1266 2001 RHEUMATOLOGY 40(8):933-938 Kari JA; Shah V; Dillon MJ Behcet's disease in UK children: clinical features and treatment including thalidomide | 5 | 16 |
| 1838 | 0 | 36 | 29 1981 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 13(6):553-562 SHANNON EJ; MIRANDA RO; MORALES MJ; HASTINGS RC INHIBITION OF DENOVO IGM ANTIBODY-SYNTHESIS BY THALIDOMIDE AS A RELEVANT MECHANISM OF ACTION IN LEPROSY | 32 | 41 |
| 1839 | 16 | 45 | 426 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):535-542 ARALACHAVES M; VILANOVA M; RIBEIRO A; PINTO J IMMUNOSTIMULATORY EFFECT OF THALIDOMIDE IN NORMAL C57BL/6 MICE IS COMPATIBLE WITH STIMULATION OF A HIGHLY CONNECTED CENTRAL IMMUNE-SYSTEM .1. | 4 | 6 |
| 1840 | 8 | 26 | 427 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):543-548 VILANOVA M; RIBEIRO A; CARNEIRO J; ARALACHAVES M THE EFFECTS OF THALIDOMIDE TREATMENT ON AUTOIMMUNE-PRONE NZB AND MRL MICE ARE CONSISTENT WITH STIMULATION OF THE CENTRAL IMMUNE-SYSTEM .2. | 4 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1841 | 15 | 33 | 741 1998 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 48(4):397-402 Zhu J; Deng GM; Diab A; Zwingenberger K; Bakhiet M; Link H Thalidomide prolongs experimental autoimmune neuritis in Lewis rats | 4 | 10 |
| 1842 | 35 | 95 | 1817 2003 SCHMERZ 17(3):204-+ Peuckmann V; Strumpf M; Zenz M; Bruera E Novel potential uses of thalidomide in the management of pain? A review of the literature | 0 | 0 |
| 1843 | 0 | 2 | 649 1997 SCIENTIST 11(3):1-& Brown KS New uses for thalidomide yielding valuable lessons | 1 | 4 |
| 1844 | 1 | 1 | 650 1997 SCIENTIST 11(3):8-8 Brown KS Researchers explore thalidomide's therapeutic potential | 0 | 0 |
| 1845 | 5 | 7 | 1267 2001 SCIENTIST 15(2):1-+ Lewis R The return of thalidomide | 0 | 1 |
| 1846 | 0 | 0 | 485 1995 SEARCH 26(10):290-290 WESTMORE A HEREDITY OF THALIDOMIDE DEFORMITY DISPUTED | 0 | 0 |
| 1847 | 0 | 0 | 651 1997 SEARCH 28(8):239-239 [Anon] Inheriting thalidomide deformities | 0 | 0 |
| 1848 | 4 | 38 | 96 1983 SEMAINE DES HOPITAUX 59(45):3101-3104 BELAUBE P; GARCIN G; MARCHAND JP; PRIVAT Y SHOULD THALIDOMIDE BE REHABILITATED | 4 | 7 |
| 1849 | 66 | 87 | 742 1998 SEMINARS IN CUTANEOUS MEDICINE AND SURGERY 17(4):231-242 Stirling DI Thalidomide and its impact in dermatology | 14 | 17 |
| 1850 | 9 | 27 | 1048 2000 SEMINARS IN HEMATOLOGY 37(1):1-4 Anderson KC Thalidomide: Therapeutic potential in hematologic malignancies | 6 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1851 | 51 | 96 | 1049 2000 SEMINARS IN HEMATOLOGY 37(1):5-14 Stirling DI Pharmacology of thalidomide | 21 | 23 |
| 1852 | 3 | 15 | 1050 2000 SEMINARS IN HEMATOLOGY 37(1):15-21 Munshi NC; Desikan KR; Barlogie B Clinical experience with thalidomide in multiple myeloma: Phase II trial results in refractory disease and ongoing studies | 5 | 6 |
| 1853 | 0 | 10 | 1051 2000 SEMINARS IN HEMATOLOGY 37(1):22-25 Alexanian R; Weber D Thalidomide for resistant and relapsing myeloma | 23 | 27 |
| 1854 | 7 | 35 | 1052 2000 SEMINARS IN HEMATOLOGY 37(1):26-34 Thomas DA Pilot studies of thalidomide in acute myelogenous leukemia, myelodysplastic syndromes, and myeloproliferative disorders | 9 | 13 |
| 1855 | 5 | 42 | 1053 2000 SEMINARS IN HEMATOLOGY 37(1):35-39 Alexanian R; Anderson KC; Barlogie B; Stirling DI; Thomas DA Thalidomide in hematologic malignancies: Future directions | 5 | 5 |
| 1856 | 6 | 48 | 1268 2001 SEMINARS IN HEMATOLOGY 38(3):250-259 Barlogie B; Zangari M; Spencer T; Fassas A; Anaissie E; Badros A; Cromer J; Tricot G Thalidomide in the management of multiple myeloma | 18 | 31 |
| 1857 | 7 | 20 | 1818 2003 SEMINARS IN HEMATOLOGY 40(4):1-2 Barlogie B Introduction: Thalidomide and the IMiDs in multiple myeloma | 0 | 0 |
| 1858 | 12 | 17 | 1819 2003 SEMINARS IN HEMATOLOGY 40(4):3-7 Alexanian R; Weber D; Anagnostopoulos A; Delasalle K; Wang M; Rankin K Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma | 0 | 0 |
| 1859 | 14 | 23 | 1820 2003 SEMINARS IN HEMATOLOGY 40(4):8-16 Dimopoulos MA; Anagnostopoulos A Thalidomide in relapsed/refractory multiple myeloma: Pivotal trials conducted outside the United States | 0 | 0 |
| 1860 | 10 | 33 | 1821 2003 SEMINARS IN HEMATOLOGY 40(4):17-22 Rajkumar SV Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1861 | 11 | 14 | 1822 2003 SEMINARS IN HEMATOLOGY 40(4):33-38 Barlogie B Thalidomide and CC-5013 in multiple myeloma: The University of Arkansas experience | 0 | 0 |
| 1862 | 8 | 40 | 1269 2001 SEMINARS IN ONCOLOGY 28(4):62-66 Figg WD; Arlen P; Gulley J; Fernandez P; Noone M; Fedenko K; Hamilton M; Parker C; Kruger EA; Pluda J; Dahut WL A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer | 16 | 38 |
| 1863 | 7 | 18 | 1270 2001 SEMINARS IN ONCOLOGY 28(6):577-582 Barlogie B; Tricot G; Anaissie E Thalidomide in the management of multiple myeloma | 10 | 17 |
| 1864 | 7 | 21 | 1271 2001 SEMINARS IN ONCOLOGY 28(6):583-587 Kyle RA; Rajkumar SV Therapeutic application of thalidomide in multiple myeloma | 5 | 9 |
| 1865 | 6 | 18 | 1272 2001 SEMINARS IN ONCOLOGY 28(6):588-592 Blade J; Esteve J; Rosinol L; Perales M; Montoto S; Tuset M; Montserrat E Thalidomide in refractory and relapsing multiple myeloma | 11 | 13 |
| 1866 | 12 | 25 | 1273 2001 SEMINARS IN ONCOLOGY 28(6):593-596 Desikan RK; Jagannath S Therapeutic dilemmas with thalidomide in multiple myeloma: Case discussions | 2 | 2 |
| 1867 | 19 | 47 | 1274 2001 SEMINARS IN ONCOLOGY 28(6):597-601 D'Amato RJ; Lentzsch S; Anderson KC; Rogers MS Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma | 0 | 10 |
| 1868 | 15 | 17 | 1275 2001 SEMINARS IN ONCOLOGY 28(6):602-606 Stirling D Thalidomide: A novel template for anticancer drugs | 8 | 13 |
| 1869 | 5 | 31 | 1551 2002 SEMINARS IN ONCOLOGY 29(6):34-38 Durie BGM Low-dose thalidomide in myeloma: Efficacy and biologic significance | 5 | 8 |
| 1870 | 6 | 25 | 1823 2003 SEMINARS IN ONCOLOGY 30(2):265-269 Dimopoulos MA; Tsatalas C; Zomas A; Hamilos G; Panayiotidis P; Margaritis D; Matsouka C; Economopoulos T; Anagnostopoulos N Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone | 3 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1871 | 7 | 29 | 1824 2003 SEMINARS IN ONCOLOGY 30(2):270-274 Coleman M; Leonard J; Lyons L; Szelenyi H; Niesvizky R Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone | 3 | 6 |
| 1872 | 13 | 35 | 864 1999 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 12(6):305-311 Monastirli A; Georgiou S; Bolsen K; Pasmatzi E; Papapanagiotou A; Goerz G; Kalofoutis A; Merk HF; Tsambaos D Treatment of porphyria cutanea tarda with oral thalidomide | 5 | 7 |
| 1873 | 8 | 30 | 865 1999 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 12(6):312-316 Kalofoutis A; Monastirli A; Papapanagiotou A; Georgiou S; Pasmatzi E; Sakkis T; Bolsen K; Goerz G; Merk HF; Tsambaos D Alterations of rat liver phospholipid composition induced by oral thalidomide | 0 | 0 |
| 1874 | 7 | 12 | 1825 2003 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 16(2):123-129 Hadgraft J; Goosen C; du Plessis J; Flynn G Predicting the dermal absorption of thalidomide and its derivatives | 0 | 0 |
| 1875 | 0 | 6 | 560 1996 SLEEP 19(2):116-116 Kanbayashi T; Nishino S; Tafti M; Hishikawa Y; Dement WC; Mignot E Thalidomide, immune modulation and narcolepsy | 0 | 2 |
| 1876 | 5 | 11 | 866 1999 SLEEP 22(1):113-115 Kanbayashi T; Shimizu T; Takahashi Y; Kitajima T; Takahashi K; Saito Y; Hishikawa Y Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study | 9 | 11 |
| 1877 | 0 | 83 | 1552 2002 SOCIAL HISTORY OF MEDICINE 15(1):137-158 Daemmrich A A tale of two experts: Thalidomide and political engagement in the United States and West Germany | 0 | 0 |
| 1878 | 0 | 68 | 1054 2000 SOCIAL STUDIES OF SCIENCE 30(1):41-71 Timmermans S; Leiter V The redemption of thalidomide: Standardizing the risk of birth defects | 0 | 1 |
| 1879 | 2 | 34 | 377 1993 SPECTROSCOPY LETTERS 26(4):597-619 ROTHCHILD R; SANDERS K; VENKATASUBBAN KS NMR-STUDIES OF DRUGS - USE OF LANTHANIDE SHIFT-REAGENTS IN POLAR-SOLVENT WITH THALIDOMIDE | 0 | 6 |
| 1880 | 13 | 40 | 867 1999 SURGERY 125(5):536-544 Kotoh T; Dhar DK; Masunaga R; Tabara H; Tachibana M; Kubota H; Kohno H; Nagasue N Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice | 12 | 27 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1881 | 3 | 4 | 1276 2001 SWISS MEDICAL WEEKLY 131(9-10):133-133 Trojan A; Anagnostara A; Fost L Thalidomide: near complete regression of extramedullary bulk in refractory multiple myeloma | 2 | 2 |
| 1882 | 69 | 104 | 1826 2003 SWISS MEDICAL WEEKLY 133(5-6):77-87 von Moos R; Stolz R; Cerny T; Gillessen S Thalidomide: from tragedy to promise | 1 | 1 |
| 1883 | 6 | 27 | 1277 2001 SYNTHESIS-STUTTGART (7):999-1000 Seijas JA; Vazquez-Tato MP; Gonzalez-Bande C; Martinez MM; Pacios-Lopez B Microwave promoted synthesis of a rehabilitated drug: Thalidomide | 0 | 2 |
| 1884 | 4 | 19 | 1827 2003 SYNTHETIC COMMUNICATIONS 33(8):1375-1382 Chang MY; Chen ST; Chang NC A synthesis of racemic thalidomide | 0 | 4 |
| 1885 | 3 | 12 | 171 1985 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 5(3):149-158 BRAUN AG; WEINREB SL TERATOGEN METABOLISM - SPONTANEOUS DECAY PRODUCTS OF THALIDOMIDE AND THALIDOMIDE ANALOGS ARE NOT BIOACTIVATED BY LIVER-MICROSOMES | 11 | 15 |
| 1886 | 6 | 38 | 293 1990 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 10(4):281-294 HUANG PHT; MCBRIDE WG THALIDOMIDE INDUCED ALTERATION IN SECONDARY STRUCTURE OF RAT EMBRYONIC DNA INVIVO | 6 | 12 |
| 1887 | 5 | 20 | 428 1994 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 14(3):115-122 HEGER W; SCHMAHL HJ; KLUG S; FELIES A; NAU H; MERKER HJ; NEUBERT D EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES IN THE NONHUMAN PRIMATE CALLITHRIX-JACCHUS .4. TERATOGENICITY OF MU-G/KG DOSES OF THE EM12 ENANTIOMERS | 7 | 15 |
| 1888 | 3 | 13 | 652 1997 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 17(1):1-5 Huang PHT; McBride WG Interaction of [glutarimide-2-C-14]-thalidomide with rat embryonic DNA in vivo | 7 | 12 |
| 1889 | 4 | 11 | 653 1997 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 17(1):R1-R2 Neubert D Never-ending tales of the mode of the teratogenic action of thalidomide | 3 | 5 |
| 1890 | 3 | 37 | 1055 2000 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 20(1):35-47 Fort DJ; Stover EL; Bantle JA; Finch RA Evaluation of the developmental toxicity of thalidomide using Frog Embryo Teratogenesis Assay-Xenopus (FETAX): Biotransformation and detoxification | 6 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1891 | 13 | 22 | 1056 2000 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 20(5):301-311 Teo S; Morgan M; Stirling D; Thomas S Assessment of the in vitro and in vivo genotoxicity of Thalomid (R) (Thalidomide) | 1 | 1 |
| 1892 | 0 | 0 | 30 1981 TERATOLOGY 23(2):A51-A51 MCCREDIE J THALIDOMIDE AND THE NEURAL CREST | 0 | 0 |
| 1893 | 0 | 0 | 31 1981 TERATOLOGY 23(2):A63-A64 STEPHENS TD; MCNULTY TR IS THALIDOMIDE EMBRYOPATHY A RESULT OF NEUROPATHY - NO | 0 | 0 |
| 1894 | 0 | 0 | 32 1981 TERATOLOGY 23(2):A65-A65 THEISEN CT; MCGREGOR EE FURTHER OBSERVATIONS ON THE DEVELOPMENT OF THALIDOMIDE INDUCED LIMB DEFORMITIES | 4 | 7 |
| 1895 | 0 | 40 | 33 1981 TERATOLOGY 23(3):351-364 NEWMAN LM; HENDRICKX AG FETAL EAR MALFORMATIONS INDUCED BY MATERNAL INGESTION OF THALIDOMIDE IN THE BONNET MONKEY (MACACA, RADIATA) | 2 | 13 |
| 1896 | 0 | 0 | 52 1982 TERATOLOGY 25(2):A28-A29 BLAKE DA; GORDON GB; SPIELBERG SP THE ROLE OF METABOLIC-ACTIVATION IN THALIDOMIDE TERATOGENESIS | 0 | 0 |
| 1897 | 1 | 2 | 53 1982 TERATOLOGY 25(2):A40-A40 FLINT OP THE EFFECT OF THALIDOMIDE ON MICROMASS CULTURES OF EMBRYONIC RAT-CELLS | 0 | 0 |
| 1898 | 0 | 0 | 54 1982 TERATOLOGY 25(2):A47-A47 HELM FC; FRANKUS E CHEMICAL-STRUCTURE AND TERATOGENIC ACTIVITY OF THALIDOMIDE-RELATED COMPOUNDS | 4 | 4 |
| 1899 | 0 | 0 | 55 1982 TERATOLOGY 25(2):A61-A61 MCBRIDE WG; VARDY P; STOKES PA THE MECHANISM OF THALIDOMIDE TERATOGENISM IN THE RABBIT LIMB | 0 | 0 |
| 1900 | 0 | 0 | 56 1982 TERATOLOGY 25(2):A75-A75 SHEPARD TH; SHIOTA K BIOACTIVATION OF THALIDOMIDE BY A MONKEY LIVER FRACTION IN A RAT LIMB CULTURE SYSTEM | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1901 | 0 | 0 | 57 1982 TERATOLOGY 26(1):A4-A4 TSUCHIYA K THALIDOMIDE EMBRYOPATHY AND ITS ALLIED CONDITIONS IN JAPAN | 0 | 0 |
| 1902 | 0 | 0 | 58 1982 TERATOLOGY 26(1):A17-A17 MIKAMI T; MATSUBARA Y; YAMANAKA H; SUZUKI Y TERATOGENIC EFFECTS OF THALIDOMIDE IN RABBITS - (3) THE DEVELOPMENTAL PROCESSES OF DYSRAPHIC MALFORMATIONS IN JW-NIBS RABBITS | 0 | 0 |
| 1903 | 0 | 0 | 59 1982 TERATOLOGY 26(3):A19-A19 OCKENFELS H; KOCHERBECKER U; KOCHER W EFFECTS OF SINGLE AND COMBINED ACTION OF A HYDROLYSIS PRODUCT OF THALIDOMIDE AND THE SURFACTANT TWEEN 20 IN MICE | 0 | 0 |
| 1904 | 0 | 6 | 97 1983 TERATOLOGY 27(2):A29-A30 BECK SL PAUCITY OF POSTNATAL EFFECTS ON CD-1 MOUSE SKELETON OF PRENATAL EXPOSURE TO CAPTAN, THALIDOMIDE, CORTISONE, OR DIPHENYLHYDANTOIN | 0 | 3 |
| 1905 | 0 | 0 | 98 1983 TERATOLOGY 27(2):A33-A33 BRAUN AG; WEINREB SL METABOLITES OF THALIDOMIDE ANALOGS INHIBIT ATTACHMENT OF CELLS TO CONCANAVALIN A COATED SURFACES | 0 | 2 |
| 1906 | 0 | 0 | 99 1983 TERATOLOGY 27(2):A80-A80 THEISEN CT THALIDOMIDE DYSMELIA IN RHESUS-MONKEYS - AN OVERVIEW | 0 | 0 |
| 1907 | 0 | 29 | 100 1983 TERATOLOGY 27(3):327-332 PARKHIE M; WEBB M EMBRYOTOXICITY AND TERATOGENICITY OF THALIDOMIDE IN RATS | 3 | 7 |
| 1908 | 0 | 0 | 101 1983 TERATOLOGY 28(1):A13-A14 MIKAMI T; MATSUBARA Y; YAMANAKA H; SUZUKI Y TERATOGENIC EFFECTS OF THALIDOMIDE IN RABBITS .4. DYSRAPHISM OF THE ANTERIOR NEUROPORE IN JW-NIBS RABBIT EMBRYOS ANALYZED BY SEM | 0 | 0 |
| 1909 | 0 | 0 | 126 1984 TERATOLOGY 29(2):A19-A20 BRAUN AG; COLLINS M; HARDING F; WEINREB S FACTORS INFLUENCING THE ACTIVATION OF THALIDOMIDE TO A PRODUCT INHIBITING ATTACHMENT OF TUMOR-CELLS TO LECTIN COATED SURFACES | 0 | 1 |
| 1910 | 0 | 0 | 127 1984 TERATOLOGY 30(1):A26-A26 KANNO O; SAITO T; ASAKA A ELECTROENCEPHALOGRAPHIC STUDY ON THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1911 | 0 | 0 | 128 1984 TERATOLOGY 30(1):A26-A26 IWAKURA H; YOSHIDA K; OGAWA T PHYSICAL-EXAMINATION OF THALIDOMIDE EMBRYOPATHY PATIENTS - PROBLEMS OF MOTOR DYSFUNCTION | 0 | 0 |
| 1912 | 0 | 0 | 129 1984 TERATOLOGY 30(1):A26-A27 SAITO T; ASAKA A; KANNO O; KIDA M PSYCHOLOGICAL-TESTS AND A STUDY OF SOCIAL-ADJUSTMENT OF PATIENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 1913 | 0 | 0 | 130 1984 TERATOLOGY 30(1):A27-A27 KIDA M MEDICAL-EXAMINATION OF THALIDOMIDE-EMBRYOPATHY - METHODOLOGY AND SUMMARY | 0 | 0 |
| 1914 | 0 | 0 | 131 1984 TERATOLOGY 30(1):A36-A36 MATSUMOTO Y; HAMADA Y FINDINGS OF THE UROGENITAL ORGAN SYSTEMS OF THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 1915 | 0 | 0 | 132 1984 TERATOLOGY 30(1):A36-A36 ARIMOTO H OCULAR FINDINGS OF THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 1916 | 0 | 0 | 133 1984 TERATOLOGY 30(1):A36-A36 TANAKA Y THALIDOMIDE-INDUCED OTOLARYNGOLOGICAL DEFECTS | 0 | 0 |
| 1917 | 0 | 0 | 134 1984 TERATOLOGY 30(1):A37-A37 KIKUCHI S ANOMALIES OF THE ORAL AND MAXILLO-FACIAL REGIONS IN THALIDOMIDE EMBRYOPATHY (JAPAN) | 0 | 0 |
| 1918 | 0 | 0 | 172 1985 TERATOLOGY 31(3):A68-A68 TESH JM; NEWALL DR TERATOGENIC EFFECTS OF THALIDOMIDE ON RAT EMBRYOS INVITRO | 0 | 1 |
| 1919 | 1 | 38 | 173 1985 TERATOLOGY 32(1):133-144 NEWMAN CGH TERATOGEN UPDATE - CLINICAL ASPECTS OF THALIDOMIDE EMBRYOPATHY - A CONTINUING PREOCCUPATION | 9 | 28 |
| 1920 | 0 | 0 | 195 1986 TERATOLOGY 33(2):A48-A49 TESH JM; NEWALL DR THALIDOMIDE AND ABNORMAL EMBRYONIC-DEVELOPMENT INVITRO | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1921 | 0 | 0 | 196 1986 TERATOLOGY 33(2):A57-A57 SCHMAHL HJ; WINKLER K; HEGER W; BARRACH HJ; NAU H PHARMACOKINETICS OF THE TERATOGENIC AND NONTERATOGENIC THALIDOMIDE ANALOGS EM-12 AND SUPIDIMID IN THE RAT AND MARMOSET MONKEY | 0 | 0 |
| 1922 | 0 | 0 | 197 1986 TERATOLOGY 34(3):415-415 HEGER W; SAMES K; MERKER HJ; FRANKUS E; GRAUDUMS I; NEUBERT D TERATOGENIC EVALUATION OF A METHYLATED THALIDOMIDE DERIVATIVE IN A PRIMATE SPECIES | 0 | 0 |
| 1923 | 0 | 0 | 214 1987 TERATOLOGY 35(2):A73-A73 HALES BF; JAIN R SPECIES-DIFFERENCES IN THE EFFECTS OF DRUG-METABOLIZING-ENZYMES ON THE TERATOGENICITY OF THALIDOMIDE IN RAT EMBRYO CULTURES | 0 | 1 |
| 1924 | 0 | 0 | 215 1987 TERATOLOGY 36(1):A8-A9 DEIONGH RU; MCCREDIE J QUANTITATIVE NEUROPATHOLOGY OF THE PERIPHERAL-NERVES IN RABBIT THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 1925 | 0 | 0 | 216 1987 TERATOLOGY 36(3):435-435 KIDA M A QUARTER CENTURY IN THE THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 1926 | 0 | 0 | 242 1988 TERATOLOGY 38(2):199-199 MCBRIDE WG; CATALANO A; DUGUID P; HICKS L THE EFFECT OF THALIDOMIDE ADMINISTRATION ON GABA AND OTHER AMINO-ACIDS IN THE MARMOSET EMBRYO | 0 | 0 |
| 1927 | 0 | 0 | 243 1988 TERATOLOGY 38(3):201-202 FRASER FC THALIDOMIDE RETROSPECTIVE - WHAT DID WE LEARN | 1 | 4 |
| 1928 | 0 | 8 | 244 1988 TERATOLOGY 38(3):203-215 LENZ W A SHORT HISTORY OF THALIDOMIDE EMBRYOPATHY | 39 | 70 |
| 1929 | 0 | 17 | 245 1988 TERATOLOGY 38(3):217-219 WARKANY J WHY I DOUBTED THAT THALIDOMIDE WAS THE CAUSE OF THE EPIDEMIC OF LIMB DEFECTS OF 1959 TO 1961 | 2 | 3 |
| 1930 | 0 | 7 | 246 1988 TERATOLOGY 38(3):221-226 KELSEY FO THALIDOMIDE UPDATE - REGULATORY ASPECTS | 17 | 29 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1931 | 7 | 61 | 247 1988 TERATOLOGY 38(3):229-239 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 40 | 64 |
| 1932 | 3 | 219 | 248 1988 TERATOLOGY 38(3):241-251 BRENT RL; HOLMES LB CLINICAL AND BASIC SCIENCE LESSONS FROM THE THALIDOMIDE TRAGEDY - WHAT HAVE WE LEARNED ABOUT THE CAUSES OF LIMB DEFECTS | 7 | 37 |
| 1933 | 1 | 2 | 294 1990 TERATOLOGY 41(2):239-239 MCCREDIE J PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY - COMMENT | 1 | 1 |
| 1934 | 3 | 12 | 295 1990 TERATOLOGY 41(2):241-242 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 1935 | 4 | 19 | 296 1990 TERATOLOGY 41(2):243-244 KOCH HP PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 2 | 4 |
| 1936 | 3 | 10 | 297 1990 TERATOLOGY 41(2):245-246 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 1 | 3 |
| 1937 | 2 | 9 | 338 1992 TERATOLOGY 46(5):411-413 LIPSON AH THALIDOMIDE RETROSPECTIVE - WHAT DID THE CLINICAL TERATOLOGIST LEARN | 0 | 3 |
| 1938 | 0 | 0 | 339 1992 TERATOLOGY 46(5):417-418 LENZ W A PERSONAL PERSPECTIVE ON THE THALIDOMIDE TRAGEDY | 2 | 5 |
| 1939 | 5 | 51 | 561 1996 TERATOLOGY 54(3):126-134 Smith DM; Torres RD; Stephens TD Mesonephros has a role in limb development and is related to thalidomide embryopathy | 0 | 6 |
| 1940 | 8 | 17 | 562 1996 TERATOLOGY 54(6):273-277 Castilla EE; AshtonProlla P; BarredaMejia E; Brunoni D; Cavalcanti DP; CorreaNeto J; Delgadillo JL; Dutra MG; Felix T; Giraldo A; Juarez N; LopezCamelo JS; Nazer J; Orioli IM; Paz JE; Pessoto MA; PinaNeto JM; Quadrelli R; Rittler M; Rueda S; Saltos M; Sanchez O; Schuler L Thalidomide, a current teratogen in South America | 14 | 17 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1941 | 69 | 136 | 868 1999 TERATOLOGY 60(5):306-321 Miller MT; Stromland K Teratogen update: Thalidomide: A review, with a focus on ocular findings and new potential uses | 7 | 19 |
| 1942 | 9 | 41 | 1057 2000 TERATOLOGY 61(3):189-195 Stephens TD; Fillmore BJ Hypothesis: Thalidomide embryopathy - Proposed mechanism of action | 17 | 30 |
| 1943 | 1 | 3 | 1058 2000 TERATOLOGY 62(3):172-173 Adams J; Buttar HS; Chambers C; Collins TFX; Graham JM; Jones KL; Kweder S; Mitala J; Polifka JE; Schwetz BA; Public Affairs Comm Teratology society public affairs committee position paper: Thalidomide | 0 | 1 |
| 1944 | 17 | 35 | 1553 2002 TERATOLOGY 66(3):115-121 Stromland K; Philipson E; Gronlund MA Offspring of male and female parents with thalidomide embryopathy: Birth defects and functional anomalies | 3 | 5 |
| 1945 | 3 | 18 | 1059 2000 TETRAHEDRON LETTERS 41(14):2275-2278 Luzzio FA; Mayorov AV; Figg WD Thalidomide metabolites. Part 1: Derivatives of (+)-2-(N-phthalimido)-gamma-hydroxyglutamic acid | 3 | 7 |
| 1946 | 7 | 25 | 1060 2000 TETRAHEDRON LETTERS 41(37):7151-7155 Luzzio FA; Thomas EM; Figg WD Thalidomide metabolites and analogs. Part 2: Cyclic derivatives of 2-N-phthalimido-2S,3S (3-hydroxy) ornithine | 4 | 6 |
| 1947 | 3 | 18 | 486 1995 TETRAHEDRON-ASYMMETRY 6(6):1249-1252 ROBIN S; ZHU J; GALONS H; PHAMHUY C; CLAUDE JR; TOMAS A; VIOSSAT B A CONVENIENT ASYMMETRIC-SYNTHESIS OF THALIDOMIDE | 8 | 19 |
| 1948 | 22 | 34 | 1554 2002 THERAPEUTIC DRUG MONITORING 24(1):104-110 Price DK; Ando Y; Kruger EA; Weiss M; Figg WD 5 '-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis | 9 | 10 |
| 1949 | 20 | 32 | 1555 2002 THERAPIE 57(6):524-529 Boulin M; Blanchet F; Isambert N; Solary E; Solier S; Collin B; Pernot C; Durnet-Archeray MJ Role of thalidomide with or without dexamethasone for refractory multiple myeloma | 0 | 0 |
| 1950 | 13 | 19 | 1972 2004 THROMBOSIS AND HAEMOSTASIS 91(4):834-836 Potenza L; Luppi M; Morselli M; Saviola A; Ferrari A; Riva G; Longo G; Marietta M; Torelli G Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1951 | 23 | 52 | 1278 2001 TOXICOLOGICAL SCIENCES 59(1):160-168 Teo SK; Evans MG; Brockman MJ; Ehrhart J; Morgan JM; Stirling DI; Thomas SD Safety profile of thalidomide after 53 weeks of oral administration in beagle dogs | 5 | 5 |
| 1952 | 29 | 56 | 1973 2004 TOXICOLOGICAL SCIENCES 81(2):379-389 Teo SK; Denny KH; Stirling DI; Thomas SD; Morseth S; Hoberman AM Effects of thalidomide on developmental, peri-and postnatal function in female New Zealand white rabbits and offspring | 0 | 0 |
| 1953 | 2 | 15 | 198 1986 TOXICOLOGY AND APPLIED PHARMACOLOGY 82(1):175-179 BRAUN AG; HARDING FA; WEINREB SL TERATOGEN METABOLISM - THALIDOMIDE ACTIVATION IS MEDIATED BY CYTOCHROME-P-450 | 27 | 34 |
| 1954 | 18 | 37 | 1061 2000 TOXICOLOGY AND APPLIED PHARMACOLOGY 165(3):237-244 Karrow NA; McCay JA; Brown RD; Musgrove DL; Pettit DA; Munson AE; Germolec DR; White KL Thalidomide stimulates splenic IgM antibody response and cytotoxic T lymphocyte activity and alters leukocyte subpopulation numbers in female B6C3F1 mice | 5 | 8 |
| 1955 | 3 | 15 | 265 1989 TOXICOLOGY LETTERS 45(1):23-33 SCHMAHL HJ; HEGER W; NAU H THE ENANTIOMERS OF THE TERATOGENIC THALIDOMIDE ANALOG EM-12 .2. CHEMICAL-STABILITY, STEREOSELECTIVITY OF METABOLISM AND RENAL EXCRETION IN THE MARMOSET MONKEY | 7 | 17 |
| 1956 | 0 | 16 | 298 1990 TOXICOLOGY LETTERS 50(2-3):309-318 SHIOTA K; UWABE C; YAMAMOTO M; ARISHIMA K SUSCEPTIBILITY TO CYCLOPHOSPHAMIDE AND THALIDOMIDE OF FETAL-RAT LIMB BUDS GRAFTED IN ATHYMIC (NUDE) MICE | 0 | 0 |
| 1957 | 1 | 20 | 199 1986 TRANSPLANTATION 41(5):644-647 VOGELSANG GB; HESS AD; GORDON G; SANTOS GW TREATMENT AND PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH THALIDOMIDE IN A RAT MODEL | 47 | 71 |
| 1958 | 7 | 26 | 299 1990 TRANSPLANTATION 49(1):20-25 TAMURA F; VOGELSANG GB; REITZ BA; BAUMGARTNER WA; HERSKOWITZ A COMBINATION THALIDOMIDE AND CYCLOSPORINE FOR CARDIAC ALLOGRAFT-REJECTION - COMPARISON WITH COMBINATION METHYLPREDNISOLONE AND CYCLOSPORINE | 20 | 27 |
| 1959 | 11 | 17 | 315 1991 TRANSPLANTATION 52(5):908-910 KEENAN RJ; EIRAS G; BURCKART GJ; STUART RS; HARDESTY RL; VOGELSANG G; GRIFFITH BP; ZEEVI A IMMUNOSUPPRESSIVE PROPERTIES OF THALIDOMIDE - INHIBITION OF INVITRO LYMPHOCYTE-PROLIFERATION ALONE AND IN COMBINATION WITH CYCLOSPORINE OR FK506 | 39 | 44 |
| 1960 | 1 | 7 | 200 1986 TRANSPLANTATION PROCEEDINGS 18(4):904-906 VOGELSANG GB; TAYLOR S; GORDON G; HESS AD THALIDOMIDE, A POTENT AGENT FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE | 19 | 27 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1961 | 2 | 6 | 217 1987 TRANSPLANTATION PROCEEDINGS 19(1):2658-2661 VOGELSANG GB; HESS AD; GORDON G; BRUNDRETTE R; SANTOS GW THALIDOMIDE INDUCTION OF BONE-MARROW TRANSPLANTATION TOLERANCE | 24 | 32 |
| 1962 | 4 | 8 | 249 1988 TRANSPLANTATION PROCEEDINGS 20(2):226-228 VOGELSANG GB; WELLS MC; SANTOS GW; CHEN TL; HESS AD COMBINATION LOW-DOSE THALIDOMIDE AND CYCLOSPORINE PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN A RAT MISMATCHED MODEL | 14 | 16 |
| 1963 | 3 | 6 | 340 1992 TRANSPLANTATION PROCEEDINGS 24(6):2560-2561 ERIKSSON T; RIESBECK K; OSTRAAT O; EKBERG H; BJORKMAN S DRUG EXPOSURE AND FLOW-CYTOMETRY ANALYSES IN A THALIDOMIDE TREATMENT SCHEDULE THAT PROLONGS RAT CARDIAC GRAFT-SURVIVAL | 6 | 7 |
| 1964 | 3 | 7 | 341 1992 TRANSPLANTATION PROCEEDINGS 24(6):2624-2625 OSTRAAT O; EKBERG H; SCHATZ H; RIESBECK K; ERIKSSON T THALIDOMIDE PROLONGS GRAFT-SURVIVAL IN RAT CARDIAC TRANSPLANTS | 9 | 9 |
| 1965 | 2 | 10 | 1974 2004 TRANSPLANTATION PROCEEDINGS 36(4):1018-1020 Chaves DNB; Petroianu A; Alberti LR; Pereira WA Effects of thalidomide, cyclosporine, and diclofenac on skin allograft survival in rabbits | 0 | 0 |
| 1966 | 0 | 0 | 342 1992 TROPICAL DOCTOR 22(3):139-139 AWOFESO N THALIDOMIDE PERIPHERAL NEUROPATHY | 1 | 4 |
| 1967 | 0 | 0 | 343 1992 TROPICAL DOCTOR 22(3):139-140 WATERS MFR THALIDOMIDE PERIPHERAL NEUROPATHY - REPLY | 2 | 4 |
| 1968 | 6 | 28 | 654 1997 TUBERCLE AND LUNG DISEASE 78(1):47-55 Moreira AL; Tsenova-Berkova L; Wang J; Laochumroonvorapong P; Freeman S; Freedman VH; Kaplan G Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis | 21 | 46 |
| 1969 | 14 | 32 | 1975 2004 UROLOGY 63(6):1061-1065 Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma | 0 | 0 |
| 1970 | 6 | 25 | 1828 2003 WORLD JOURNAL OF SURGERY 27(10):1119-1123 Mall JW; Schwenk W; Philipp AW; Buttemeyer R; Pollmann C Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1971 | 12 | 23 | 1829 2003 XENOTRANSPLANTATION 10(5):470-474 Yamamoto S; Cooper DKC An investigation of the effect of thalidomide on anti-gal antibody production in baboons | 0 | 0 |
| 1972 | 0 | 8 | 34 1981 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 36(9-10):904-906 KOCHERBECKER U; KOCHER W; OCKENFELS H THALIDOMIDE-LIKE MALFORMATIONS CAUSED BY A TWEEN SURFACTANT IN MICE | 3 | 6 |
| 1973 | 1 | 17 | 201 1986 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 41(11-12):1057-1061 KOCH HP; CZEJKA MJ EVIDENCE FOR THE INTERCALATION OF THALIDOMIDE INTO DNA - CLUE TO THE MOLECULAR MECHANISM OF THALIDOMIDE TERATOGENICITY | 8 | 10 |
| 1974 | 4 | 37 | 344 1992 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 47(1-2):155-169 KOCHERBECKER U; KOCHER W; OCKENFELS H EMBRYOTOXIC INTERACTIONS BETWEEN A HYDROLYSIS PRODUCT OF THALIDOMIDE AND THE SURFACTANT TWEEN 20 IN MICE | 0 | 0 |
| 1975 | 0 | 0 | 102 1983 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 121(4):526-526 RUFFING L DISTURBANCES OF DISK DIFFERENTIATION DUE TO THALIDOMIDE | 0 | 0 |